Extended Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Long Is Too Long?
作者信息
Howard Charles E, Nambi Vijay, Jneid Hani, Khalid Umair
机构信息
Section of Cardiology Department of Medicine Baylor College of Medicine Houston TX.
Section of Cardiology Medical Care Line Michael E. DeBakey VA Medical Center Houston TX.
出版信息
J Am Heart Assoc. 2019 Oct 15;8(20):e012639. doi: 10.1161/JAHA.119.012639. Epub 2019 Oct 2.
Abstract
摘要
相似文献
1
Extended Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Long Is Too Long?
J Am Heart Assoc. 2019 Oct 15;8(20):e012639. doi: 10.1161/JAHA.119.012639. Epub 2019 Oct 2.
2
Duration of Dual Antiplatelet Therapy and Late Stent Thrombosis Following Percutaneous Coronary Intervention with Second-Generation Drug-Eluting Stents: A Simple Meta-Analysis of Randomized Controlled Trials.
Adv Ther. 2019 Nov;36(11):3166-3173. doi: 10.1007/s12325-019-01091-5. Epub 2019 Sep 18.
3
Meta-analysis of Dual Antiplatelet Therapy Versus Monotherapy With P2Y12 Inhibitors in Patients After Percutaneous Coronary Intervention.
Am J Cardiol. 2020 Jul 15;127:25-29. doi: 10.1016/j.amjcard.2020.04.027. Epub 2020 Apr 22.
4
Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation.
Am J Cardiol. 2020 Aug 15;129:122-124. doi: 10.1016/j.amjcard.2020.05.012. Epub 2020 May 18.
5
Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
JACC Cardiovasc Interv. 2013 Sep;6(9):932-42. doi: 10.1016/j.jcin.2013.04.022.
6
Efficacy and Safety of Guideline-Recommended Risk Score-Directed Dual Antiplatelet Therapy After 2nd-Generation Drug-Eluting Stents.
Circ J. 2020 Jan 24;84(2):161-168. doi: 10.1253/circj.CJ-19-0667. Epub 2019 Dec 13.
7
Long-Term Efficacy of Extended Dual Antiplatelet Therapy After Left Main Coronary Artery Bifurcation Stenting.
Am J Cardiol. 2020 Feb 1;125(3):320-327. doi: 10.1016/j.amjcard.2019.10.046. Epub 2019 Nov 7.
8
Safety and efficacy of antiplatelet regimens after percutaneous coronary intervention using drug eluting stents: A network meta-analysis of randomized controlled trials.
Prog Cardiovasc Dis. 2020 May-Jun;63(3):243-248. doi: 10.1016/j.pcad.2020.03.018. Epub 2020 Apr 3.
9
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study.
Am Heart J. 2019 Mar;209:97-105. doi: 10.1016/j.ahj.2018.10.009. Epub 2018 Nov 22.
10
Optimal Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: An Umbrella Review.
Can J Cardiol. 2019 Aug;35(8):1039-1046. doi: 10.1016/j.cjca.2019.01.021. Epub 2019 Feb 6.
引用本文的文献
1
Comparison of Different Chronic Maintenance Antithrombotic Strategies in Patients with Coronary Artery Disease: A Systematic Review and Network Meta-Analysis.
Cardiovasc Ther. 2023 Aug 17;2023:5446271. doi: 10.1155/2023/5446271. eCollection 2023.
2
Evaluation of the safety and efficacy of a Polyzene-F nanocoated coronary stent system: A systematic review and single-arm meta-analysis.
Front Cardiovasc Med. 2023 Mar 16;10:1095794. doi: 10.3389/fcvm.2023.1095794. eCollection 2023.
3
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: State-of-the-Art Review.
JACC CardioOncol. 2021 Nov 16;3(5):619-634. doi: 10.1016/j.jaccao.2021.08.011. eCollection 2021 Dec.
4
From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease.
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211005097. doi: 10.1177/23247096211005097.
5
Longer or shorter dual antiplatelet therapy in dialysis patients receiving a coronary drug-eluting stent? A rope game still ongoing.
Clin Kidney J. 2020 May 6;13(5):749-752. doi: 10.1093/ckj/sfaa040. eCollection 2020 Oct.
本文引用的文献
1
Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial.
BMJ. 2018 Oct 2;363:k3793. doi: 10.1136/bmj.k3793.
2
[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.].
Kardiol Pol. 2017;75(12):1217-1299. doi: 10.5603/KP.2017.0224.
3
Study protocol for a randomised controlled trial: harmonising optimal strategy for treatment of coronary artery stenosis - coronary intervention with next-generation drug-eluting stent platforms and abbreviated dual antiplatelet therapy (HOST-IDEA) trial.
BMJ Open. 2017 Oct 11;7(10):e016617. doi: 10.1136/bmjopen-2017-016617.
4
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.
J Am Coll Cardiol. 2016 Oct 25;68(17):1851-1864. doi: 10.1016/j.jacc.2016.07.760. Epub 2016 Aug 29.
5
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.
J Am Coll Cardiol. 2016 May 17;67(19):2224-2234. doi: 10.1016/j.jacc.2016.02.064. Epub 2016 Apr 11.
6
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
J Am Coll Cardiol. 2016 Jun 14;67(23):2719-2728. doi: 10.1016/j.jacc.2016.03.524. Epub 2016 Apr 1.
7
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54.
J Am Coll Cardiol. 2016 Jun 14;67(23):2732-2740. doi: 10.1016/j.jacc.2016.03.529. Epub 2016 Apr 1.
8
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.
Circulation. 2016 Sep 6;134(10):e123-55. doi: 10.1161/CIR.0000000000000404. Epub 2016 Mar 29.
9
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
JAMA. 2016 Apr 26;315(16):1735-49. doi: 10.1001/jama.2016.3775.
10
Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Eur Heart J. 2016 Jan 21;37(4):400-8. doi: 10.1093/eurheartj/ehv482. Epub 2015 Oct 5.
Zotero 插件